XDJP ETF Analysis: Nikkei 225 1D | XETRA
Japan Large-Cap Blend Equity | XETRA, Germany | Market Cap: 361.718m EUR | 12M Return: 46.5% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 5.05M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
The Xtrackers Nikkei 225 UCITS ETF 1D (XDJP) is a Germany-domiciled exchange-traded fund that aims to track the performance of the Nikkei Stock Average Index, which comprises 225 large-cap stocks listed on the Tokyo Stock Exchange First Section. The fund falls within the Japan Large-Cap Blend Equity category and is managed on a passive basis by Deutsche Asset Management (UK) Limited as the Sub-Portfolio Manager. As a passive index-tracking product in the ETF sector, it generates revenue primarily through management fees tied to assets under management.
The underlying Index maintains long-term continuity through periodic reviews of constituent shares, which are evaluated based on liquidity and sector balance. Liquidity is assessed by ranking shares according to trading volume and the magnitude of price fluctuations by volume over the preceding 5 years. The Fund seeks to replicate the Index by holding all or a substantial portion of its constituent shares in the same proportions as the Index. The benchmark used is the Morningstar Japan TME NR JPY.
- Bank of Japan rate hike path reshapes Nikkei outlook
- Yen depreciation lifts Japanese exporter earnings forecasts
- Foreign investor inflows accelerate amid Japan reflation trade
As of July 28, 2026, the stock is trading at EUR 35.38 with a total of 446,210 shares traded. Over the past week, the price has changed by -3.45%, over one month by -9.58%, over three months by +6.23% and over the past year by +46.46%.
Current recommended Stop Loss: 34.30 (which is 3.1% or 1.2 ATR below the current price).
Nikkei 225 1D has no consensus analysts rating.